Imidazole derivatives
    31.
    发明授权
    Imidazole derivatives 失效
    咪唑衍生物

    公开(公告)号:US5179111A

    公开(公告)日:1993-01-12

    申请号:US284223

    申请日:1988-12-14

    摘要: Imidazole derivatives of general Formula I ##STR1## wherein R.sup.1 means hydrogen, an optionally substituted C.sub.1-10 hydrocarbon or hetaryl residue, or a cyclic ether residue,R.sup.2 means hydrogen, halogen, an optionally substituted amino, nitro, azide, thiocyanate or cyano group, a linear or branched C.sub.1-10 -alkyl residue optionally substituted with halogen, or -OR.sup.1 wherein R.sup.1 has the above-mentioned meanings, andR.sup.1 and R.sup.2 jointly with the oxygen atom form a saturated or unsaturated 5- to 7-membered ring which can contain still another hetero atom,R.sup.3 means hydrogen, a linear or branched C.sub.1-6 -alkyl group, or a C.sub.1-6 -alkoxyalkyl group,R.sup.4 means -COOR.sup.5, -CONR.sup.6 R.sup.7, -CN, ##STR2## and their use as medicinal agents are disclosed.

    摘要翻译: 通式I的咪唑衍生物其中R 1表示氢,任选取代的C 1-10烃或杂芳基残基或环醚残基,R 2表示氢,卤素,任选取代的氨基,硝基,叠氮基,硫氰酸酯 或氰基,任选被卤素取代的直链或支链C 1-10 - 烷基或-OR 1,其中R 1具有上述含义,并且R 1和R 2与氧原子一起形成饱和或不饱和的5-至7- 可以含有另外的杂原子的三元环,R 3表示氢,直链或支链C 1-6 - 烷基或C 1-6 - 烷氧基烷基,R 4表示-COOR 5,-CONR 6 R 7,-CN, 作为药剂使用。